Sana Biotechnology, Inc.

Sana Biotechnology develops medical treatments made from engineered cells, the goal being to treat diseases that currently have few good options. The company is working on cell therapies for type 1 diabetes, autoimmune diseases, and certain cancers. Its main approach involves modifying cells to make them less likely to be rejected by the patient's immune system, then infusing them back into the body. The company is in early stages of testing these therapies in patients.